Chinese patients with adult onset leukodystrophy caused by <i>CST3</i> variants

Yi Zhang; Zhi-Ying Wu

doi:10.1016/j.jgg.2024.05.002

Volume 51 Issue 7

Jul. 2024

Turn off MathJax

Article Contents

Article Navigation > Journal of Genetics and Genomics > 2024 > 51(7): 778-780

PDF( 621 KB)

Chinese patients with adult onset leukodystrophy caused by CST3 variants

doi: 10.1016/j.jgg.2024.05.002

Yi Zhang^1,2,3,
Zhi-Ying Wu^4,5,6,7

1. Department of Medical Genetics and Center for Rare Diseases, Zhejiang Key Laboratory of Rare Diseases for Precision Medicine and Clinical Translation, Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310009, China;
2. Nanhu Brain-computer Interface Institute, Hangzhou, Zhejiang 314050, China;
3. Department of Neurology, Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310009, China;
4. Department of Medical Genetics and Center for Rare Diseases, Zhejiang Key Laboratory of Rare Diseases for Precision Medicine and Clinical Translation, Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310009, China;
5. Nanhu Brain-computer Interface Institute, Hangzhou, Zhejiang 314050, China;
6. Department of Neurology, Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310009, China;
7. MOE Frontier Science Center for Brain Science and Brain-machine Integration, School of Brain Science and Brain Medicine, Zhejiang University, Hangzhou, Zhejiang 310012, China

Funds:

This study was supported by the grant (82230062) from the National Natural Science Foundation of China to Zhi-Ying Wu.

Received Date: 2024-04-29
Accepted Date: 2024-05-05
Rev Recd Date: 2024-05-05

Available Online: 2025-06-06

Publish Date: 2024-05-08

Abstract

FullText(HTML)

References(16)

References

Bergner, C.G., Breur, M., Soto-Bernardini, M.C., Schafer, L., Lier, J., Le Duc, D., Bundalian, L., Schubert, S., Brenner, D., Kreuz, F.R., et al., 2024. Dominant CST3 variants cause adult onset leukodystrophy without amyloid angiopathy. Brain, awae085.

Cathcart, H.M., Huang, R., Lanham, I.S., Corder, E.H., Poduslo, S.E., 2005. Cystatin C as a risk factor for Alzheimer disease. Neurology 64, 755-757.

Chen, S., Ni, W., Yin, X.Z., Liu, H.Q., Lu, C., Zheng, Q.J., Zhao, G.X., Xu, Y.F., Wu, L., Zhang, L., et al., 2017. Clinical features and mutation spectrum in Chinese patients with CADASIL: a multicenter retrospective study. CNS Neurosci. Ther. 23, 707-716.

Grubb, A., Lofberg, H., 1982. Human gamma-trace, a basic microprotein: amino acid sequence and presence in the adenohypophysis. Proc. Natl. Acad. Sci. U.S.A. 79, 3024-3027.

Kaeser, S.A., Herzig, M.C., Coomaraswamy, J., Kilger, E., Selenica, M.L., Winkler, D.T., Staufenbiel, M., Levy, E., Grubb, A., Jucker, M., 2007. Cystatin C modulates cerebral beta-amyloidosis. Nat. Genet. 39, 1437-1439.

Kohler, W., Curiel, J., Vanderver, A., 2018. Adulthood leukodystrophies. Nat. Rev. Neurol. 14, 94-105.

Mathews, P.M., Levy, E., 2016. Cystatin C in aging and in Alzheimer's disease. Ageing Res. Rev. 32, 38-50.

Ni, W., Zhang, Y., Zhang, L., Xie, J.J., Li, H.F., Wu, Z.Y., 2022. Genetic spectrum of NOTCH3 and clinical phenotype of CADASIL patients in different populations. CNS Neurosci. Ther. 28, 1779-1789.

Palsdottir, A., Abrahamson, M., Thorsteinsson, L., Arnason, A., Olafsson, I., Grubb, A., Jensson, O., 1988. Mutation in cystatin C gene causes hereditary brain haemorrhage. Lancet 2, 603-604.

Richards, S., Aziz, N., Bale, S., Bick, D., Das, S., Gastier-Foster, J., Grody, W.W., Hegde, M., Lyon, E., Spector, E., et al., 2015. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American college of medical genetics and genomics and the association for molecular pathology. Genet. Med. 17, 405-424.

Tolomeo, P., Butt, J.H., Kondo, T., Campo, G., Desai, A.S., Jhund, P.S., Kober, L., Lefkowitz, M.P., Rouleau, J.L., Solomon, S.D., et al., 2023. Importance of cystatin C in estimating glomerular filtration rate: the PARADIGM-HF trial. Eur. Heart J. 44, 2202-2212.

Wei, Q., Luo, W.J., Yu, H., Wang, P.S., Dong, H.L., Li, H.F., Wu, Z.Y., 2021. A novel PCYT2 mutation identified in a Chinese consanguineous family with hereditary spastic paraplegia. J. Genet. Genomics 48, 751-754.

Wu, K., Bu, F., Wu, Y., Zhang, G., Wang, X., He, S., Liu, M.F., Chen, R., Yuan, H., 2024. Exploring noncoding variants in genetic diseases: from detection to functional insights. J. Genet. Genomics 51, 111-132.

Xie, J.J., Ni, W., Wei, Q., Ma, H., Bai, G., Shen, Y., Wu, Z.Y., 2020. New clinical characteristics and novel pathogenic variants of patients with hereditary leukodystrophies. CNS Neurosci. Ther. 26, 567-575.

Zhang, Y., Wu, Z.Y., 2024. Gene therapy for monogenic disorders: challenges, strategies, and perspectives. J. Genet. Genomics 51, 133-143.

Zurdel, J., Finckh, U., Menzer, G., Nitsch, R.M., Richard, G., 2002. CST3 genotype associated with exudative age related macular degeneration. Br. J. Ophthalmol. 86, 214-219.

Relative Articles

Supplements(0)

Cited By

Proportional views